| 47.66 |  -0.20 / -0.42% |
Data as of 4:03pm ET | Day’s Change |
| 47.66 |  0.00 / 0.00% |
Volume: 1.1K |
| Twin Launch by ResMed - Analyst Blog Jun 04 / Zacks.com |
| Previous close | 47.86 |
| Today’s open | 47.66 |
| Day’s range | 47.39 - 47.93 |
| Volume | 591,869 |
| Average volume (3 months) | 1,029,405 |
| Market cap | $6.8B |
| Dividend yield | 1.43% |
| Earnings growth (last year) | +18.75% |
| Earnings growth (this year) | +26.02% |
| Earnings growth (next 5 years) | +15.30% |
| Revenue growth (last year) | +10.08% |
| P/E ratio | 22.4 |
| Price/Sales | 3.33 |
| Price/Book | 4.23 |
| Today’s change | Today’s % change | |
|---|---|---|
| VARVarian Medical Syste... | +1.15 | +1.65% |
| TFXTeleflex Inc | +0.73 | +0.94% |
| THORThoratec Corp | -0.39 | -1.22% |
| HTWRHeartWare Internatio... | +1.68 | +1.81% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.62 |
| Annual revenue (last year) | $1.4B |
| Annual profit (last year) | $254.9M |
| Net profit margin | 18.62% |
Sector Health Technology |
Industry Medical Specialties |
Executive Chairman Peter C. Farrell, PhD |
President & Chief Operating Officer Robert Andrew Douglas, MBA |
Corporate headquarters San Diego, California |
.
